pyridoxamine has been researched along with Schizophrenia in 4 studies
Schizophrenia: A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this clinical trial was to obtain proof of concept for high-dose pyridoxamine as a novel treatment for schizophrenia with enhanced carbonyl stress." | 7.88 | Pyridoxamine: A novel treatment for schizophrenia with enhanced carbonyl stress. ( Amano, N; Arai, M; Dan, T; Horiuchi, Y; Ichikawa, T; Ishimoto, K; Itokawa, M; Kobori, A; Miyashita, M; Miyata, T; Okazaki, Y; Takahashi, K; Tokunaga, T; Toriumi, K; Usami, S; Washizuka, S; Yoshikawa, T, 2018) |
| "The aim of this clinical trial was to obtain proof of concept for high-dose pyridoxamine as a novel treatment for schizophrenia with enhanced carbonyl stress." | 3.88 | Pyridoxamine: A novel treatment for schizophrenia with enhanced carbonyl stress. ( Amano, N; Arai, M; Dan, T; Horiuchi, Y; Ichikawa, T; Ishimoto, K; Itokawa, M; Kobori, A; Miyashita, M; Miyata, T; Okazaki, Y; Takahashi, K; Tokunaga, T; Toriumi, K; Usami, S; Washizuka, S; Yoshikawa, T, 2018) |
| "Glycylglycine was also significantly (p=0." | 1.46 | Metabolic profile alterations in the postmortem brains of patients with schizophrenia using capillary electrophoresis-mass spectrometry. ( Fujii, T; Hattori, K; Kunugi, H; Miyakawa, T; Ohashi, Y; Sato, H, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Itokawa, M | 2 |
| Miyashita, M | 2 |
| Arai, M | 2 |
| Dan, T | 1 |
| Takahashi, K | 1 |
| Tokunaga, T | 1 |
| Ishimoto, K | 1 |
| Toriumi, K | 2 |
| Ichikawa, T | 1 |
| Horiuchi, Y | 2 |
| Kobori, A | 2 |
| Usami, S | 1 |
| Yoshikawa, T | 1 |
| Amano, N | 1 |
| Washizuka, S | 1 |
| Okazaki, Y | 1 |
| Miyata, T | 1 |
| Ozaki, N | 1 |
| Fujii, T | 1 |
| Hattori, K | 1 |
| Miyakawa, T | 1 |
| Ohashi, Y | 1 |
| Sato, H | 1 |
| Kunugi, H | 1 |
1 review available for pyridoxamine and Schizophrenia
| Article | Year |
|---|---|
Carbonyl stress and schizophrenia.
Topics: Arginine; Biomarkers; Glycation End Products, Advanced; Humans; Lactoylglutathione Lyase; Lysine; Mu | 2014 |
3 other studies available for pyridoxamine and Schizophrenia
| Article | Year |
|---|---|
Pyridoxamine: A novel treatment for schizophrenia with enhanced carbonyl stress.
Topics: Adult; Antipsychotic Agents; Arginine; Drug Therapy, Combination; Female; Humans; Lactoylglutathione | 2018 |
Right treatment for the right schizophrenic patients based on carbonyl stress pathophysiology.
Topics: Glycation End Products, Advanced; Humans; Oxidative Stress; Pyridoxamine; Schizophrenia | 2018 |
Metabolic profile alterations in the postmortem brains of patients with schizophrenia using capillary electrophoresis-mass spectrometry.
Topics: Adult; Analysis of Variance; Brain; Electrophoresis, Capillary; Female; Glycylglycine; Humans; Lacti | 2017 |